A. Andrieux, P. A. Salin, M. Vernet, P. Kujala, J. Baratier et al., The suppression of brain cold-stable microtubules in mice induces synaptic defects associated with neuroleptic-sensitive behavioral disorders, Genes & Development, vol.16, issue.18, pp.2350-64, 2002.
DOI : 10.1101/gad.223302

C. Bosc, J. D. Cronk, F. Pirollet, D. M. Watterson, J. Haiech et al., Cloning, expression, and properties of the microtubule-stabilizing protein STOP., Proceedings of the National Academy of Sciences, vol.93, issue.5, pp.2125-2155, 1996.
DOI : 10.1073/pnas.93.5.2125

P. Brun, M. Begou, A. Andrieux, L. Mouly-badina, M. Clerget et al., Dopaminergic transmission in STOP null mice, Journal of Neurochemistry, vol.65, issue.1, pp.63-73, 2005.
DOI : 10.1016/0165-0173(90)90015-G
URL : https://hal.archives-ouvertes.fr/inserm-00380189

J. H. Callicott, R. E. Straub, L. Pezawas, M. F. Egan, V. S. Mattay et al., Variation in DISC1 affects hippocampal structure and function and increases risk for schizophrenia, Proceedings of the National Academy of Sciences, vol.102, issue.24, pp.8627-8659, 2005.
DOI : 10.1073/pnas.0500515102

T. C. Chou, X. G. Zhang, A. Balog, D. S. Su, D. Meng et al., Desoxyepothilone B: An efficacious microtubule-targeted antitumor agent with a promising in vivo profile relative to epothilone B, Proceedings of the National Academy of Sciences, vol.95, issue.16, pp.9642-9649, 1998.
DOI : 10.1073/pnas.95.16.9642

A. A. Chubykin, X. Liu, D. Comoletti, I. Tsigelny, P. Taylor et al., Dissection of Synapse Induction by Neuroligins: EFFECT OF A NEUROLIGIN MUTATION ASSOCIATED WITH AUTISM, Journal of Biological Chemistry, vol.280, issue.23, pp.22365-74, 2005.
DOI : 10.1074/jbc.M410723200

C. Dillon and Y. Goda, THE ACTIN CYTOSKELETON: Integrating Form and Function at the Synapse, Annual Review of Neuroscience, vol.28, issue.1, pp.25-55, 2005.
DOI : 10.1146/annurev.neuro.28.061604.135757

C. G. Dotti, C. A. Sullivan, and G. A. Banker, The establishment of polarity by hippocampal neurons in culture, J Neurosci, vol.8, pp.1454-68, 1988.

R. L. Fradley, G. O-'meara, F. Newman, R. J. Andrieux, A. Job et al., STOP knockout and NMDA NR1 hypomorphic mice exhibit deficits in sensorimotor gating, Behavioural Brain Research, vol.163, issue.2, pp.257-64, 2005.
DOI : 10.1016/j.bbr.2005.05.012
URL : https://hal.archives-ouvertes.fr/inserm-00380197

W. G. Frankle, J. Lerma, and M. Laruelle, The Synaptic Hypothesis of Schizophrenia, Neuron, vol.39, issue.2, pp.205-221, 2003.
DOI : 10.1016/S0896-6273(03)00423-9

L. Guillaud, C. Bosc, A. Fourest-lieuvin, E. Denarier, F. Pirollet et al., STOP Proteins are Responsible for the High Degree of Microtubule Stabilization Observed in Neuronal Cells, The Journal of Cell Biology, vol.15, issue.1, pp.167-79, 1998.
DOI : 10.1083/jcb.133.1.151

I. H. Hardt, H. Steinmetz, K. Gerth, F. Sasse, H. Reichenbach et al., , Strains So ce90/B2 and So ce90/D13:?? Isolation, Structure Elucidation, and SAR Studies, Journal of Natural Products, vol.64, issue.7, pp.847-56, 2001.
DOI : 10.1021/np000629f

P. J. Harrison and M. J. Owen, Genes for schizophrenia? Recent findings and their pathophysiological implications, The Lancet, vol.361, issue.9355, pp.417-426, 2003.
DOI : 10.1016/S0140-6736(03)12379-3

P. J. Harrison and D. R. Weinberger, Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence, Molecular Psychiatry, vol.10, issue.8, p.804, 2005.
DOI : 10.1038/sj.mp.4001686

G. Hofle and H. Reichenbach, Epothilone, A Myxobacterial Metabolite with Promising Antitumor Activity, pp.413-449, 2005.
DOI : 10.1201/b11185-22

S. Jamain, H. Quach, C. Betancur, M. Rastam, C. Colineaux et al., Mutations of the X-linked genes encoding neuroligins NLGN3 and NLGN4 are associated with autism, Mutations of the Xlinked genes encoding neuroligins NLGN3 and NLGN4 are associated with autism, pp.27-36, 2003.
DOI : 10.1038/ng1136
URL : https://hal.archives-ouvertes.fr/inserm-00124744

A. Kolman, BMS-310705 Bristol-Myers Squibb/GBF, Curr Opin Investig Drugs, vol.5, pp.1292-1299, 2004.

C. Konradi and S. Heckers, Antipsychotic drugs and neuroplasticity: insights into the treatment and neurobiology of schizophrenia, Biological Psychiatry, vol.50, issue.10, pp.729-771, 2001.
DOI : 10.1016/S0006-3223(01)01267-7

F. Laumonnier, F. Bonnet-brilhault, M. Gomot, R. Blanc, A. David et al., X-Linked Mental Retardation and Autism Are Associated with a Mutation in the NLGN4 Gene, a Member of the Neuroligin Family, The American Journal of Human Genetics, vol.74, issue.3, pp.552-559, 2004.
DOI : 10.1086/382137

K. Mirnics, F. A. Middleton, D. A. Lewis, and P. Levitt, Analysis of complex brain disorders with gene expression microarrays: schizophrenia as a disease of the synapse, Trends in Neurosciences, vol.24, issue.8, pp.479-86, 2001.
DOI : 10.1016/S0166-2236(00)01862-2

J. A. Morris, G. Kandpal, L. Ma, and C. P. Austin, DISC1 (Disrupted-In-Schizophrenia 1) is a centrosome-associated protein that interacts with MAP1A, MIPT3, ATF4/5 and NUDEL: regulation and loss of interaction with mutation, Human Molecular Genetics, vol.12, issue.13, pp.1591-608, 2003.
DOI : 10.1093/hmg/ddg162

J. H. Nettles, H. Li, B. Cornett, J. M. Krahn, J. P. Snyder et al., The Binding Mode of Epothilone A on ??,??-Tubulin by Electron Crystallography, Science, vol.305, issue.5685, pp.866-875, 2004.
DOI : 10.1126/science.1099190

K. Okamoto, T. Nagai, A. Miyawaki, and Y. Hayashi, Rapid and persistent modulation of actin dynamics regulates postsynaptic reorganization underlying bidirectional plasticity, Nature Neuroscience, vol.83, issue.10, pp.1104-1116, 2004.
DOI : 10.1038/nature02617

M. J. Owen, N. Craddock, M. O-'donovan, and C. , Schizophrenia: genes at last?, Trends in Genetics, vol.21, issue.9, pp.518-543, 2005.
DOI : 10.1016/j.tig.2005.06.011

M. J. Owen, M. C. O-'donovan, and P. J. Harrison, Schizophrenia: a genetic disorder of the synapse?, BMJ, vol.330, issue.7484, pp.158-167, 2005.
DOI : 10.1136/bmj.330.7484.158

L. Pani, A. Porcella, and G. L. Gessa, The role of stress in the pathophysiology of the dopaminergic system, Molecular Psychiatry, vol.5, issue.1, pp.14-21, 2000.
DOI : 10.1038/sj.mp.4000589

T. L. Petryshen, F. A. Middleton, A. Kirby, K. A. Aldinger, S. Purcell et al., Support for involvement of neuregulin 1 in schizophrenia pathophysiology, Molecular Psychiatry, vol.10, issue.4, pp.366-74, 2005.
DOI : 10.1038/sj.mp.4001608

S. K. Schultz and N. C. Andreasen, Schizophrenia, The Lancet, vol.353, issue.9162, pp.1425-1455, 1999.
DOI : 10.1016/S0140-6736(98)07549-7
URL : https://hal.archives-ouvertes.fr/hal-00633986

G. P. Shumyatsky, G. Malleret, R. M. Shin, S. Takizawa, K. Tully et al., stathmin, a Gene Enriched in the Amygdala, Controls Both Learned and Innate Fear, ): stathmin, a gene enriched in the amygdala, controls both learned and innate fear, pp.697-709, 2005.
DOI : 10.1016/j.cell.2005.08.038

H. Stefansson, V. Steinthorsdottir, T. E. Thorgeirsson, J. R. Gulcher, and K. Stefansson, Neuregulin 1 and schizophrenia, Annals of Medicine, vol.103, issue.1, pp.62-71, 2004.
DOI : 10.1074/jbc.M100602200

J. L. Thompson, M. F. Pogue-geile, and A. A. Grace, Developmental Pathology, Dopamine, and Stress: A Model for the Age of Onset of Schizophrenia Symptoms, Schizophrenia Bulletin, vol.30, issue.4, pp.875-900, 2004.
DOI : 10.1093/oxfordjournals.schbul.a007139

D. Van-rossum and U. K. Hanisch, Cytoskeletal dynamics in dendritic spines: direct modulation by glutamate receptors?, Trends in Neurosciences, vol.22, issue.7, pp.290-295, 1999.
DOI : 10.1016/S0166-2236(99)01404-6

H. Wang, Z. Wang, S. Wang, M. Li, L. Nan et al., Preclinical pharmacology of epothilone D, a novel tubulin-stabilizing antitumor agent, Cancer Chemotherapy and Pharmacology, vol.43, issue.3, pp.255-60, 2005.
DOI : 10.1007/s00280-004-0965-0

J. Yan, G. Oliveira, A. Coutinho, C. Yang, J. Feng et al., Analysis of the, 2005.
URL : https://hal.archives-ouvertes.fr/hal-01007505